Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

More filters
Clear filters

ARTV · buys only · $50K+ · 96 trades

Trades
96
Buys 96 · Sells 0
People
6
Stocks
1
Disclosed value
$106M
range midpoints · Congress & executive
Filed late
0
  1. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  2. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  3. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  4. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  5. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  6. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  7. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  8. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  9. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  10. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  11. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  12. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  13. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  14. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  15. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  16. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  17. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  18. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  19. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
  20. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  21. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade
  22. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
  23. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  24. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$596Kdisclosed Jul 23 · filed the same day
  25. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade